FDA wants yet more data on Takeda diabetes drug alogliptin

Article Date: 26/04/2012 10:00
FDA wants yet more data on Takeda diabetes drug alogliptin

Vacancy Search

Quick job search

Advanced Search

Latest News

Eisai's lenvatinib to get speedy review in Europe

Eisai's lenvatinib to get speedy review in Europe

Dementia diagnoses in England surge 62% in 7 years

Dementia diagnoses in England surge 62% in 7 years

New NICE knockback for Celgene myeloma drug

New NICE knockback for Celgene myeloma drug

Pfizer nabs Baxter vaccines for $635m

Pfizer nabs Baxter vaccines for $635m

UPDATE: AZ shells out $2.1bn for Almirall's lung drugs

UPDATE: AZ shells out $2.1bn for Almirall's lung drugs

Third US OK for Regeneron’s Eylea

Third US OK for Regeneron’s Eylea

Targacept dumps second drug, this time for overactive bladder

Targacept dumps second drug, this time for overactive bladder

Merck & Co sees Q2 profit rocket

Merck & Co sees Q2 profit rocket

EU expands use of Pfizer/B-MS bloodthinner Eliquis

EU expands use of Pfizer/B-MS bloodthinner Eliquis

Indefinite delay for care.data after patient fiasco

Indefinite delay for care.data after patient fiasco
more news